ICU Medical (NASDAQ:ICUI) Share Price Crosses Above 200-Day Moving Average - Here's What Happened

ICU Medical, Inc. (NASDAQ:ICUI - Get Free Report) shares crossed above its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $157.00 and traded as high as $162.01. ICU Medical shares last traded at $160.99, with a volume of 133,187 shares traded.

Analyst Upgrades and Downgrades

ICUI has been the topic of a number of analyst reports. KeyCorp increased their price target on ICU Medical from $198.00 to $209.00 and gave the stock an "overweight" rating in a research report on Wednesday, November 13th. Needham & Company LLC reissued a "hold" rating on shares of ICU Medical in a report on Wednesday, November 13th. Jefferies Financial Group raised ICU Medical from a "hold" rating to a "buy" rating and set a $200.00 price target for the company in a research note on Wednesday, December 11th. Raymond James raised their price objective on ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research note on Thursday, September 12th. Finally, StockNews.com raised ICU Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, November 20th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. Based on data from MarketBeat, ICU Medical has a consensus rating of "Moderate Buy" and a consensus target price of $199.67.

ICU Medical Trading Down 4.1 %

The firm has a 50-day simple moving average of $163.34 and a 200-day simple moving average of $157.00. The company has a quick ratio of 1.03, a current ratio of 2.29 and a debt-to-equity ratio of 0.75. The stock has a market cap of $3.78 billion, a PE ratio of -33.77 and a beta of 0.63.

Insiders Place Their Bets

In other ICU Medical news, CEO Vivek Jain sold 1,373 shares of the firm's stock in a transaction dated Thursday, January 2nd. The shares were sold at an average price of $155.48, for a total value of $213,474.04. Following the completion of the sale, the chief executive officer now owns 104,593 shares of the company's stock, valued at $16,262,119.64. This trade represents a 1.30 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. Also, COO Christian B. Voigtlander sold 1,430 shares of the company's stock in a transaction on Wednesday, November 27th. The stock was sold at an average price of $158.00, for a total value of $225,940.00. The disclosure for this sale can be found here. In the last quarter, insiders sold 29,737 shares of company stock valued at $4,941,832. Corporate insiders own 6.70% of the company's stock.

Hedge Funds Weigh In On ICU Medical

Several institutional investors and hedge funds have recently modified their holdings of the stock. Allworth Financial LP raised its position in shares of ICU Medical by 100.0% during the 3rd quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock worth $36,000 after purchasing an additional 100 shares during the last quarter. Xponance Inc. boosted its stake in ICU Medical by 6.0% during the second quarter. Xponance Inc. now owns 1,977 shares of the medical instruments supplier's stock worth $235,000 after buying an additional 112 shares during the period. Equitable Trust Co. increased its holdings in ICU Medical by 2.2% in the 3rd quarter. Equitable Trust Co. now owns 5,213 shares of the medical instruments supplier's stock valued at $950,000 after purchasing an additional 112 shares during the last quarter. Hexagon Capital Partners LLC raised its holdings in shares of ICU Medical by 162.7% in the 3rd quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock valued at $36,000 after buying an additional 122 shares during the period. Finally, Connable Office Inc. boosted its stake in shares of ICU Medical by 6.4% in the third quarter. Connable Office Inc. now owns 2,031 shares of the medical instruments supplier's stock valued at $370,000 after purchasing an additional 122 shares during the period. Institutional investors and hedge funds own 96.10% of the company's stock.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.